Your browser doesn't support javascript.
loading
Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer.
Argiris, A; Bauman, J E; Ohr, J; Gooding, W E; Heron, D E; Duvvuri, U; Kubicek, G J; Posluszny, D M; Vassilakopoulou, M; Kim, S; Grandis, J R; Johnson, J T; Gibson, M K; Clump, D A; Flaherty, J T; Chiosea, S I; Branstetter, B; Ferris, R L.
Afiliação
  • Argiris A; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio athanassios.argiris@gmail.com.
  • Bauman JE; Division of Hematology/Oncology, Department of Medicine.
  • Ohr J; Department of Medicine, Division of Hematology/Oncology.
  • Gooding WE; Department of Biostatistics.
  • Heron DE; Department of Medicine, Division of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh.
  • Duvvuri U; Division of Otolaryngology, Department of Medicine, University of Pittsburgh, Pittsburgh.
  • Kubicek GJ; Division of Radiation Oncology, Department of Medicine, Cooper University Healthcare, Camden.
  • Posluszny DM; Division of Biobehavioral Oncology, Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, USA.
  • Vassilakopoulou M; Division of Hematology/Oncology, Department of Medicine, Hopital de la Pitie-Salpetriere, Paris, France.
  • Kim S; Division of Otolaryngology, Department of Medicine, University of Pittsburgh, Pittsburgh.
  • Grandis JR; Division of Otolaryngology, Department of Medicine, University of California, San Francisco.
  • Johnson JT; Division of Otolaryngology, Department of Medicine, University of Pittsburgh, Pittsburgh.
  • Gibson MK; Division of Hematology/Oncology, Department of Medicine, UH Case Medical Center, Cleveland.
  • Clump DA; Department of Medicine, Division of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh.
  • Flaherty JT; Division of Hematology/Oncology, Department of Medicine.
  • Chiosea SI; Division of Pathology, Department of Medicine, University of Pittsburgh, Pittsburgh, USA.
  • Branstetter B; Department of Medicine, Division of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh.
  • Ferris RL; Division of Otolaryngology, Department of Medicine, University of Pittsburgh, Pittsburgh.
Ann Oncol ; 27(8): 1594-600, 2016 08.
Article em En | MEDLINE | ID: mdl-27177865
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Fator A de Crescimento do Endotélio Vascular / Receptores ErbB / Pemetrexede / Cetuximab / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Fator A de Crescimento do Endotélio Vascular / Receptores ErbB / Pemetrexede / Cetuximab / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article